Helix Biopharma: Fiscal Q4 Earnings Snapshot

In This Article:

TORONTO (AP) — TORONTO (AP) — Helix Biopharma Corp. (HBPCF) on Thursday reported a loss of $3.9 million in its fiscal fourth quarter.

The Toronto-based company said it had a loss of 8 cents per share.

For the year, the company reported a loss of $6.8 million, or 15 cents per share.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on HBPCF at https://www.zacks.com/ap/HBPCF